Asia-Pacific Amniotic Products Market Forecast to 2028 – COVID

Asia-Pacific Amniotic Products Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type [Amniotic Membranes (Cryopreserved Amniotic Membranes and Dehydrated Amniotic Membranes) and Amniotic Suspensions], Application (Wound Care, Orthopedics, Ophthalmology, and Other Applications), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Other End Users)

Report Code : BMIRE00026174 | Region : Asia Pacific | Industry : Pharmaceuticals | Published Date : 22/Sep/2022

The APAC amniotic products market is expected to grow from US$ 251.74 million in 2022 to US$ 582.01 million by 2028; it is estimated to grow at a CAGR of 8.8% from 2022 to 2028.

Regenerative medicine is concerned with the functional regeneration of tissues and organs in patients suffering from catastrophic injuries and chronic diseases. The phenomenal breakthrough in stem cell research has provided the groundwork for cell-based therapeutics for resistant diseases to traditional treatments. Stem cells are the boundaries of regenerative medicine because of their unlimited self-renewal and ability to differentiate into numerous types of cells. Ex vivo remodeling of stem cells grown into 3D organoids and tissue architectures for tailored applications has been endorsed by advances in gene editing and tissue engineering technology. In recent years, stem cell therapy has become a promising and advanced scientific study area. Due to its excellent trapping capabilities, it can also be used as a nano-reservoir for drug administration. In the clinic, the Amnio-M has evolved from a simple sheet for topical applications for skin and corneal repair to more advanced forms, such as micronized dehydrated membrane, amniotic cytokine extract, and solubilized powder injections to regenerate muscles, cartilage, and tendons, over the last century. Thus, the increasing demand for amniotic membranes in stem cell research and regenerative medicine is anticipated to boost the demand for amniotic products, resulting in market growth during the forecast period.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC amniotic products market . The APAC amniotic products market is expected to grow at a good CAGR during the forecast period.

APAC Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

APAC Amniotic Products Market Segmentation

The APAC amniotic products market is bifurcated based on type, application, end user and country. Based on type, the market is segmented into amniotic membranes, and amniotic suspensions. The amniotic membranes segment dominated the market in 2022 and is expected to be fastest growing during forecast period. Based on application, the market is segmented into wound care, orthopedics, ophthalmology, and other applications. The wound care segment dominated the market in 2022 and orthopedics segment is expected to be fastest growing during forecast period. Based on end user, the market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment dominated the market in 2022 and ambulatory surgical centers segment is expected to be fastest growing during forecast period. Based on country, the APAC amniotic products market is segmented into China, Japan, India, Australia, South Korea, and Rest of APAC.

Integra LifeSciences; Katena Products. Inc.; MiMedx; NuVision Biotherapies Ltd; Organogenesis, Inc.; Sanuwave and Sanuwave Health, Inc.; Smith & Nephew; and Stryker are among the leading companies in the APAC amniotic products market.

At 8.8% CAGR, the APAC Amniotic Product Market is speculated to be worth US$ 416.98 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the APAC amniotic product market was valued at US$ 251.74 million in 2022 and is expected to reach US$ 416.98 million by 2028, registering an annual growth rate of 8.8% from 2022 to 2028. Implementation of the 21st century cures act and increasing demand for stem cell research and regenerative medicine are the critical factors attributed to the market expansion.

In December 2016, the 21st Century Cures Act was passed. This new law was passed with the goal of advancing regenerative medicine research and medical innovation. The Act contains several provisions that could impact the development and approval of many products in the coming years. A new "Regenerative Medicine Advanced Therapy" classification and a fast-track approval procedure for innovative regenerative medicine products and therapies have been developed as a result of this Act. The 21st Century Cures Act was created to help speed up medication development and approval processes, allowing for faster and more efficient delivery of new medical advancements to patients. The application of these requirements is expected to improve interoperability and facilitate electronic health information access, exchange, and use. Therefore, the rise in funding allocation to surgery in low and middle-income countries would offer significant opportunities for the amniotic products market during the forecast period.

On the contrary, complications and limitations associated with the use of amniotic membranes secret hurdles the growth of APAC amniotic product market.

Based on type, the APAC amniotic product market is segmented into amniotic membranes and amniotic suspensions. The amniotic membranes segment held 84.2% market share in 2022, amassing US$ 211.96 million. It is projected to garner US$ 361.22 million by 2028 to expand at 9.3% CAGR during 2022–2028.

Based on application, the APAC amniotic product market is segmented into wound care, orthopedics, ophthalmology, and other applications. The periodontics segment held 39.4% market share in 2022, amassing US$ 99.21 million. It is projected to garner US$ 161.4 million by 2028 to expand at 8.5% CAGR during 2022–2028.

Based on end user, the APAC amniotic product market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held 49.0% market share in 2022, amassing US$ 123.47 million. It is projected to garner US$ 206.39 million by 2028 to expand at 8.9% CAGR during 2022–2028.

Based on country, the APAC amniotic product market is segmented into China, Japan, India, Australia, South Korea, and Rest of APAC. Our regional analysis states that Germany captured 27.5% market share in 2022. It was assessed at US$ 69.34 million in 2022 and is likely to hit US$ 118.16 million by 2028, exhibiting a CAGR of 9.3% during the forecast period.

Key players dominating the APAC amniotic product market are Integra LifeSciences; Katena Products. Inc.; MiMedx; NuVision Biotherapies Ltd; Organogenesis, Inc.; Sanuwave and Sanuwave Health, Inc.; Smith & Nephew; and Stryker among others.

In Jun 2021, MiMedx Group, Inc. announced successful regulatory approval from the Japanese Ministry of Health, Labor and Welfare (JMHLW) known to market EPIFIX in Japan. The geographic expansion will increase revenue and customer bases. This will ensure growth in the further development in the nearby region. In Jan 2020, Integra LifeSciences Holdings Corporation entered into a definitive agreement to acquire ACell, Inc. (ACell) for a $300 million cash upfront payment at closing subject to customary purchase price adjustments and cash payments of up to an additional $100 million upon achievement of certain revenue growth milestones. ACell is an innovative regenerative medicine company with a product portfolio based on MatriStem UBM, a proprietary porcine bladder matrix platform technology. The transaction is expected to close in the first quarter of 2021, subject to the satisfaction of customary conditions, including regulatory approvals. The acquisition of ACell is the next step in expanding Integras' Orthopedics and Tissue Technologies (OTT) segment. Following the completion of the previously announced sale of Integras' orthopedic business, which is expected to occur in early January, OTT will be referred to as the Tissue Technologies segment.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Amniotic Products Market – By Type

1.3.2 APAC Amniotic Products Market – By Application

1.3.3 APAC Amniotic Products Market – By End User

1.3.4 APAC Amniotic Products Market – By Country

2. APAC Amniotic Products Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Amniotic Products Market – Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Amniotic Products Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidence of Burn Injuries

5.1.2 Increasing Number of Traumatic Wounds

5.2 Market Restraints

5.2.1 Complications and Limitations Associated with Use of Amniotic Membranes

5.3 Market Opportunities

5.3.1 Implementation of the 21st Century Cures Act

5.4 Future Trends

5.4.1 Increasing Demand for Stem Cell Research and Regenerative Medicine

5.5 Impact Analysis

6. Amniotic Products Market– APAC Analysis

6.1 APAC Amniotic Products Market Revenue Forecast and Analysis

6.1.1 Overview

7. APAC Amniotic Products Market Revenue and Forecast to 2028 – by Type

7.1 Overview

7.2 APAC Amniotic Products Market, by Type, 2022 & 2028 (%)

7.3 Amniotic Membranes

7.3.1 Overview

7.3.2 Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Cryopreserved Amniotic Membranes

7.3.2.1.1 Cryopreserved Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Dehydrated Amniotic Membranes

7.3.2.2.1 Dehydrated Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

7.4 Amniotic Suspensions

7.4.1 Overview

7.4.2 Amniotic Suspensions: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

8. APAC Amniotic Products Market Revenue and Forecast to 2028 – by Application

8.1 Overview

8.2 APAC Amniotic Products Market Share by Application - 2022 & 2028 (%)

8.3 Wound Care

8.3.1 Overview

8.3.2 Wound Care: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

8.4 Orthopedics

8.4.1 Overview

8.4.2 Orthopedics: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

8.5 Ophthalmology

8.5.1 Overview

8.5.2 Ophthalmology: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

8.6 Other Applications

8.6.1 Overview

8.6.2 Other Applications: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

9. APAC Amniotic Products Market Revenue and Forecast to 2028 – by End User

9.1 Overview

9.2 APAC Amniotic Products Market Share by End User - 2022 & 2028 (%)

9.3 Hospitals and Clinics

9.3.1 Overview

9.3.2 Hospitals and Clinics: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

9.4 Ambulatory Surgical Centers

9.4.1 Overview

9.4.2 Ambulatory Surgical Centers: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

9.5 Other End Users

9.5.1 Overview

9.5.2 Other End Users: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

10. APAC Amniotic Products Market Revenue and Forecast to 2028 – by Country

10.1 Overview

10.1.1 Asia Pacific: Amniotic Products Market, by Country, 2022 & 2028 (%)

10.1.1.1 China: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1 China: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.2 China: Amniotic Products Market, By Type, 2019–2028 (USD Million)

10.1.1.1.2.1 China Amniotic Products Market in Amniotic Membranes, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3 China: Amniotic Products Market, By Application, 2019–2028 (USD Million)

10.1.1.1.4 China: Amniotic Products Market, by End User, 2019–2028 (USD Million)

10.1.1.2 Japan: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1 Japan: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.2 Japan: Amniotic Products Market, By Type, 2019–2028 (USD Million)

10.1.1.2.2.1 Japan Amniotic Products Market in Amniotic Membranes, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3 Japan: Amniotic Products Market, By Application, 2019–2028 (USD Million)

10.1.1.2.4 Japan: Amniotic Products Market, by End User, 2019–2028 (USD Million)

10.1.1.3 India: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1 India: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.2 India: Amniotic Products Market, By Type, 2019–2028 (USD Million)

10.1.1.3.2.1 India Amniotic Products Market in Amniotic Membranes, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3 India: Amniotic Products Market, By Application, 2019–2028 (USD Million)

10.1.1.3.4 India: Amniotic Products Market, by End User, 2019–2028 (USD Million)

10.1.1.4 Australia: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.1 Australia: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.2 Australia: Amniotic Products Market, By Type, 2019–2028 (USD Million)

10.1.1.4.2.1 Australia Amniotic Products Market in Amniotic Membranes, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3 Australia: Amniotic Products Market, By Application, 2019–2028 (USD Million)

10.1.1.4.4 Australia: Amniotic Products Market, by End User, 2019–2028 (USD Million)

10.1.1.5 South Korea: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.1 South Korea: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.2 South Korea: Amniotic Products Market, By Type, 2019–2028 (USD Million)

10.1.1.5.2.1 South Korea Amniotic Products Market in Amniotic Membranes, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3 South Korea: Amniotic Products Market, By Application, 2019–2028 (USD Million)

10.1.1.5.4 South Korea: Amniotic Products Market, by End User, 2019–2028 (USD Million)

10.1.1.6 Rest of Asia Pacific: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.1 Rest of Asia Pacific: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.2 Rest of Asia Pacific: Amniotic Products Market, By Type, 2019–2028 (USD Million)

10.1.1.6.2.1 Rest of Asia Pacific Amniotic Products Market in Amniotic Membranes, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3 Rest of Asia Pacific: Amniotic Products Market, By Application, 2019–2028 (USD Million)

10.1.1.6.4 Rest of Asia Pacific: Amniotic Products Market, by End User, 2019–2028 (USD Million)

11. APAC Amniotic Products Market–Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 MiMedx

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Smith & Nephew

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Integra LifeSciences

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Stryker

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Katena Products. Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 NuVision Biotherapies Ltd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Organogenesis, Inc.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Sanuwave and Sanuwave Health, Inc.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1.             APAC Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Table 2.             China: Amniotic Products Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             China Amniotic Products Market in Amniotic Membranes, by Type – Revenue and Forecast to 2028 (USD Million)

Table 4.             China: Amniotic Products Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 5.             China: Amniotic Products Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 6.             Japan: Amniotic Products Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 7.             Japan Amniotic Products Market in Amniotic Membranes, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Japan: Amniotic Products Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 9.             Japan: Amniotic Products Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 10.          India: Amniotic Products Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          India Amniotic Products Market in Amniotic Membranes, by Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          India: Amniotic Products Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 13.          India: Amniotic Products Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 14.          Australia: Amniotic Products Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Australia Amniotic Products Market in Amniotic Membranes, by Type – Revenue and Forecast to 2028 (USD Million)

Table 16.          Australia: Amniotic Products Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 17.          Australia: Amniotic Products Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 18.          South Korea: Amniotic Products Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 19.          South Korea Amniotic Products Market in Amniotic Membranes, by Type – Revenue and Forecast to 2028 (USD Million)

Table 20.          South Korea: Amniotic Products Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 21.          South Korea: Amniotic Products Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of Asia Pacific: Amniotic Products Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of Asia Pacific Amniotic Products Market in Amniotic Membranes, by Type – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of Asia Pacific: Amniotic Products Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 25.          Rest of Asia Pacific: Amniotic Products Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 26.          Organic Developments Done by Companies

Table 27.          Inorganic Developments Done by Companies

Table 28.          Glossary of Terms, APAC Amniotic Products Market

LIST OF FIGURES.

Figure 1.           APAC Amniotic Products Market Segmentation

Figure 2.           APAC Amniotic Products Market – By Country

Figure 3.           APAC Amniotic Products Market Overview

Figure 4.           Amniotic Membranes Held Largest Share by Type of Amniotic Products Market

Figure 5.           China to Show Significant Growth During Forecast Period

Figure 6.           APAC: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           APAC Amniotic Products Market Impact Analysis of Drivers and Restraints

Figure 9.           APAC Amniotic Products Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 10.        APAC Amniotic Products Market, by Type, 2022 & 2028 (%)

Figure 11.        APAC Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        APAC Cryopreserved Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        APAC Dehydrated Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        APAC Amniotic Suspensions: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        APAC Amniotic Products Market Share by Application - 2022 & 2028 (%)

Figure 16.        APAC Wound Care: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 17.        APAC Orthopedics: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 18.        APAC Ophthalmology: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 19.        APAC Other Applications: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 20.        APAC Amniotic Products Market Share by End User - 2022 & 2028 (%)

Figure 21.        APAC Hospitals and Clinics: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 22.        APAC Ambulatory Surgical Centers: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 23.        APAC Other End Users: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 24.        Asia Pacific: Amniotic Products Market, by Key Country – Revenue (2022) (USD Million)

Figure 25.        Asia Pacific: Amniotic Products Market, by Country, 2022 & 2028 (%)

Figure 26.        China: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        Japan: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        India: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Australia: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        South Korea: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        Rest of Asia Pacific: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

The List of Companies - Asia-Pacific Amniotic Products Market

● Integra LifeSciences

● Katena Products. Inc.

● MiMedx

● NuVision Biotherapies Ltd

● Organogenesis, Inc.

● Sanuwave and Sanuwave Health, Inc.

● Smith & Nephew

● Stryker

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC amniotic products market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the APAC amniotic products market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the amniotic products market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP